skip to primary navigationskip to content
 

Heparin acts as a structural component of β-endorphin amyloid fibrils rather than a simple aggregation promoter

Nespovitaya N, Mahou P, Laine RF, Kaminski Schierle GS, Kaminski CF, "Heparin acts as a structural component of β-endorphin amyloid fibrils rather than a simple aggregation promoter"Chem. Commun. (2017), 53, 1273-1276.

DOI: 10.1039/C6CC09770G | pdf | Supplementary info


Abstract

The aggregation promoter heparin is commonly used to study the aggregation kinetics and biophysical properties of protein amyloids. However, the underlying mechanism for amyloid promotion by heparin remains poorly understood. In the case of the neuropeptide β-endorphin that can reversibly adopt a functional amyloid form in nature, aggregation in the presence of heparin leads to a loss of function. Applying correlative optical super-resolution microscopy methods, we show that heparin incorporates into emerging β-endorphin fibrils forming an integral component and is essential for amyloid templating. This will have direct implications on β-endorphin’s normal physiological function and raises concerns on the biological relevance of heparin-promoted amyloid models.